Evaluation of Current Knowledge, Awareness and Practice of Spirometry among Hospital -based Nigerian Doctors by Desalu, Olufemi O et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Pulmonary Medicine
Open Access Research article
Evaluation of Current Knowledge, Awareness and Practice of 
Spirometry among Hospital -based Nigerian Doctors
Olufemi O Desalu*1, Olusegun A Busari†2, Cajetan C Onyedum†3, 
Fatai K Salawu†4, Olusegun A Obateru†1, Kelechukwu C Nwogu†5 and 
Alakija K Salami†1
Address: 1Department of Medicine, University of Ilorin Teaching Hospital Ilorin, Nigeria, 2Department of Medicine, Federal Medical Centre Ido-
Ekiti, Nigeria, 3Department of Medicine, University of Nigeria Teaching Hospital Enugu, Nigeria, 4Department of Medicine, Federal Medical 
Centre, Yola, Nigeria and 5Department of Medicine, Federal Medical Centre Birnin Kebbi, Nigeria
Email: Olufemi O Desalu* - femuy1967@yahoo.co.uk; Olusegun A Busari - olusegun_busari@yahoo.com; 
Cajetan C Onyedum - cajjonyedum@yahoo.co.uk; Fatai K Salawu - dr_abdulsalawu@yahoo.com; Olusegun A Obateru - obatyus@yahoo.com; 
Kelechukwu C Nwogu - kelechken2002@yahoo.com; Alakija K Salami - salkaz2000@yahoo.com
* Corresponding author    †Equal contributors
Abstract
Background: Spirometry is a cost-effective diagnostic tool for evaluation of lung function and for case-finding in a
resource-limited setting. The acceptance of this test depends on the awareness of its indications and the ability to
interpret the results. No studies have assessed the knowledge of spirometry among Nigerian doctors. The aim of this
study was to evaluate the current knowledge, awareness and practice of spirometry among hospital-based Nigerian
doctors.
Methods: We carried out a cross-sectional survey among 321 doctors working in Nigerian hospitals between March
2008 and June 2008. Information on knowledge, awareness, practice of and barriers to spirometry were obtained using
a pre-tested, self-administered structured questionnaire and the data were then analysed.
Results: Of the 321 doctors that participated, 108 (33.6%) reported that they have good knowledge of spirometry. One
hundred and ninety-five (60.7%) were aware of the importance of spirometry in aiding the diagnosis of respiratory
diseases; 213(66.4%) were aware of the importance of spirometry in determining the severity of diseases. Medical school
was the most common source of knowledge on spirometry (64.5%). Eighty-one (25.2%) doctors reported having a
spirometer in their hospitals. Doctors having access to a spirometer used it more frequently for aiding the diagnosis of
COPD (40.7% vs.27.5%) and for monitoring of asthma (18.5% vs.11.3%) than those without access to a spirometer. The
doctors working in University Teaching Hospitals and Federal Medical Centres (FMC) (22.4% vs. 4.5%) and those having
access to a spirometer (40.7 vs.11.3%) were very confident of interpreting spirometry results compared to those
working in District and General Hospitals and without access to a spirometer. Irrespective of access to a spirometer or
the type of hospital they were employed in, doctors reported that unavailability of a spirometer was the greatest barrier
to its use (62.5%) followed by lack of awareness about its usefulness (17.2%).
Conclusion: The knowledge and practice of spirometry were poor among hospital-based Nigerian doctors because of
unavailability of spirometers in most hospitals. These findings have implications for further evaluation, planning and
management of patient care in respiratory disease. Spirometers should be made available in all hospitals, and the
knowledge of spirometry should be improved among doctors.
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Background
Spirometry is the timed measurement of dynamic lung
volumes during forced expiration and inspiration to
quantify how effectively and how quickly the lungs can be
emptied and filled [1]. Spirometry is often used to
improve diagnosis and to monitor acute and chronic res-
piratory diseases. Respiratory diseases refer to a variety of
preventable and non-preventable chronic diseases of the
airways and other structures of the lung [2]. Research has
shown that many respiratory illnesses can be prevented,
diagnosed at an early stage and controlled with adequate
management [3]. Appropriate management of a respira-
tory morbidity requires obtaining a good history of symp-
toms and clinical signs as well conducting relevant
investigations. In most low-income countries, imaging
and endoscopy services are mostly unavailable, and doc-
tors have limited access to tools like chest radiographs and
spirometry for evaluation of respiratory diseases. Spirom-
etry is essential for the identification of many respiratory
disease states and for the objective monitoring of
responses to therapy [4,5]. A spirometry test substantially
improves diagnostic competence and case-finding of dis-
eases like COPD if applied in a pre-selected high-risk pop-
ulation [6]. A spirometry test can facilitate diagnosis and
aid in the management of most restrictive lung diseases.
Abnormal spirometry is an indicator of increased risk for
premature death from all causes, and several insurance
companies' recommends indicate it as a prerequisite for
obtaining a life insurance policy [5]. Spirometry can also
be used preoperatively to determine the cardio-respiratory
status of surgical patients, to measure lung age and to aid
in smoking cessation [5]. Although studies have been
published on spirometry reference values and ventilatory
function tests in chronic obstructive lung disease among
the Nigerian population [7,8], there are no studies that
evaluate the knowledge, awareness and practice of
spirometry among doctors in Nigeria. The aim of this
study was to evaluate the current knowledge, awareness
and practice of spirometry among hospital-based Nige-
rian doctors.
Methods
Study setting and Design
This is a cross-sectional study involving 321 doctors work-
ing in Nigerian hospitals between March 2008 and June
2008. Nigeria is located in West Africa and is divided into
6 geopolitical zones. The country has a population of 145
million, with an annual growth rate of 2.2% [9]. The ratio
of district and private hospitals to the University Teaching
Hospitals (UTH) and Federal Medical Centres (FMC) is
10:1.
Sample selection
This survey was conducted in five of the six geopolitical
zones which can be considered a representative sample of
Nigerian doctors. The investigators selected one district
hospital, one privately owned hospital and one University
Teaching Hospital or Federal Medical Centre (FMC) in
each geopolitical zone. These hospitals were selected for
reasons of convenience and easy coordination by the
zonal investigators. (See appendix for the list of selected
hospitals.) A total of 15 Nigerian hospitals (5 geopolitical
zones × 3) were selected for the study. The zonal investi-
gators coordinated the administration of the question-
naires. The doctors in the participating hospitals were
selected by simple random sampling to minimize bias;
however, interns and laboratory physicians were excluded
from this study.
Survey instrument
We used a pre-tested, self-administered structured ques-
tionnaire that was prepared using statements on spirome-
try by the American Thoracic Society (ATS) and the
European Respiratory Society [4], and questions that have
been used in two previous studies [10,11]. The question-
naire was in English, which is the official language of com-
munication in Nigeria. For construction and content
validity, the questionnaire was reviewed by two respira-
tory physicians. There was 80% agreement on the 25 ques-
tions and their wording. We tested the questionnaire for
face validity in a pilot study on 20 doctors to ascertain if
the questions were acceptable and their wording was well
understood by the respondents.
The test-retest reliability of the instrument at a two-week
interval was r = 0.78 and the internal consistency was
Crohnbach's alpha = 0.71. (See the additional file 1 for
the questionnaire.)
The selected doctors gave oral consent to the zonal inves-
tigators or signed an informed consent form to participate
in the study. A few doctors, however, preferred oral con-
sent over signing the informed consent form, in order to
avoid personal identification. The purpose of the study
was explained to the doctors in the information note
attached to questionnaire and their right to withdraw was
ensured. Physicians who consented to participate in the
study were requested to complete the questionnaire
according to their own knowledge and awareness of the
subject, in a quiet environment without interference from
their colleagues. Socio-demographic information of each
participating physician and data regarding location of
practice, years of experience, number of patients with res-
piratory diseases seen per week, and tobacco smokers
encountered per week were obtained. In addition, each
doctor was asked to respond to 25 questions: 8 were
related to awareness, self-reported knowledge and inter-
pretation of spirometry; 11 pertained to spirometry prac-
tice in their hospitals, 6 were related to attendance of
general CME programmes, sources of current knowledge,BMC Pulmonary Medicine 2009, 9:50 http://www.biomedcentral.com/1471-2466/9/50
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availability of spirometers in hospitals and barriers to use
of spirometry. The responses to the questionnaires were
collated by the zonal investigators and sent to the statisti-
cian. Anonymity and confidentiality of the participants
were guaranteed.
Data analysis
Data obtained were analysed using SPSS statistical soft-
ware version 15 (SPSS Inc., Chicago, IL, USA). Frequency
and descriptive statistics were used to examine the general
characteristics of the physicians. The participating doctors
were stratified into two groups on the basis of the reported
availability of a spirometer in their hospital and type of
hospital where they were employed (University Teaching
Hospital/FMC or district/private Hospital). The responses
of the doctors to questions on practice of and barriers to
spirometry were analysed according to the stratification.
Chi square test was used to assess the significance of the
responses and a P value of < 0.05 was considered statisti-
cally significant.
Ethical approval
The study was approved by the ethics and research com-
mittee of the Federal Medical Centre of Ido-Ekiti, Nigeria.
Results
Of the 450 questionnaires that were distributed, 321 were
returned by the doctors, leading to a response rate of
71.3%. Two hundred fifty-two (78.5%) of the 321 doctors
were men and 69 (21.5%) were women; their mean age
was 34 ± 4.4 years. Eighty-one (25.2%) doctors reported
having a spirometer in their hospitals. Other characteris-
tics of the participating doctors are given in table 1.
Awareness of the role of spirometry
Of 321 the medical doctors that participated in this study,
195 (60.7%) reported that spirometry was very important
in the diagnosis of respiratory diseases; 213(66.4%)
reported that it was very important in determining the
severity of the respiratory disease. Furthermore, the major-
ity of the doctors, 228 (71.0%), stated that spirometry was
useful for monitoring the progression of a respiratory dis-
ease, 180 doctors (56.1%) reported that the spirometry
was useful for surveillance of occupational lung disease
and 171(53.3%) reported the test to be useful for pre-
operative evaluation of surgical patients and assessment
of individuals applying for a life insurance policy. In this
study, 135 doctors (42.1%) reported lack of awareness
regarding spirometry role in determining the prognosis of
a respiratory disease.
Knowledge of spirometry
In response to questions determining the lung function
tests that would be performed on patients with suspected
bronchial asthma or COPD, 189 (58.9%) of the surveyed
doctors reported that they would measure peak flow rate,
63 (19.6%) stated that they would opt for baseline
spirometry and 39 (12.1%) said that they would perform
acute reversibility testing using a bronchodilator. One
hundred fifty-six (48.6%) doctors reported that they have
fair knowledge of spirometry, 108 (33.6%) reported to
have good knowledge while 57 (17.8%) stated that they
Table 1: Characteristics of the participating doctors
Characteristics Mean (SD), n (%)
Age 34(4.4)yrs
Respiratory diseases cases/wk 12.7(12.4)
Sex
Male 252(78.5)
Female 69(21.5)
Years of practice
<5 169(52.6)
>5 152(47.4)
location of practice
Urban 267(83.2)
Rural 54(16.8)
Types of hospital
District/private 66(20.6)
University/FMC 255(79.4)
Availability of spirometer in workplace
Yes 81(25.2)
No 240(74.8)
Awareness of guideline on spirometry interpretation
Yes 90(28.0)
No 231(72.0)
SD = standard deviationBMC Pulmonary Medicine 2009, 9:50 http://www.biomedcentral.com/1471-2466/9/50
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have poor knowledge of spirometry. The majority of the
participants, 207 (64.5%), reported that medical school
was the most common source of knowledge on spirome-
try, followed by continuing medical education pro-
grammes 87 (27.1%), internet websites 15 (4.7%) and
medical textbooks and journals 12 (3.7%). This study also
revealed that 69(21.5%) of the surveyed doctors had
attended a CME programme in general medicine in the
previous year, while 21(6.5%) had done so in the previ-
ous 2 to 5 years.
Practice of spirometry
We found that 53 (65.4%) of the 81 doctors with access to
a spirometer used spirometry more frequently as com-
pared to 46 (19.2%) of 240 doctors without access. Doc-
tors with access to a spirometer frequently used it for
aiding the diagnosis of COPD (40.7% vs.27.5%), moni-
toring of asthma (18.5% vs.11.3%), assessment of pre-
employment baseline lung function (11.1% vs.11.0%)
compared to those without access to it. Sixty of the 321
participating doctors (18.7%) reported that they were very
confident of interpreting spirometry results, 168 (52.3%)
were slightly confident and 93 (29%) were not confident
of their interpretation skills. Thirty three (40.7%) of the
doctors with access to spirometers reported that they were
very confident of interpreting spirometry results com-
pared to 11.3% of those without access to spirometers.
Other responses to questions on the practice of spirome-
try are given in table 2. Further stratification of the
responses of doctors according to the type of hospital
showed that doctors working in University Teaching Hos-
pital and Federal Medical Centre reported that they fre-
quently request spirometry for diagnosing COPD (34.1%
vs.18.2%), pre-employment evaluation (10.6% vs.9.1%)
and were very confident of interpreting spirometry results
(22.4% vs.4.5%) compared to doctors working in district
and private hospitals. Relevant data are given in table 3.
Barriers to spirometry practice
Irrespective of the doctors' access to a spirometer or the
type of hospital they worked in, unavailability, 207
(62.5%) was the greatest barrier to the use of spirometry
followed by lack of awareness of its usefulness,
57(17.2%). Other reported barriers are given in table 4
and illustrated in figure 1.
Discussion
This study shows that the majority of Nigerian doctors
were aware of the role of spirometry in the diagnosis,
assessment and progression monitoring of respiratory dis-
Table 2: Distribution of doctors' responses to questions on practice of spirometry as related to access to spirometry in the hospitals
Access to spirometry
Yes No
Questions related to practice of spirometry n (%) n (%) Total
1. How frequently do you use spirometry in your practice?
Very often 53(65.4) 46(19.2) 99(30.8)
Occasionally 25(30.9) 128(53.3) 153(47.7)
Rarely 0(0.0) 54(22.5) 54(16.8)
Never/can't recall 3(3.7) 12(5.0) 15(4.6)
2. How frequently do you request spirometry for monitoring for asthma?
Frequently depending on control 15(18.5) 27(11.3) 42(13.1)
Once a year 9(11.1) 9(3.8) 18(5.6)
Every follow up 39(48.2) 48(20.0) 87(27.1)
Never 18(22.2) 156(65.0) 174(54.2)
3. How frequently do you request spirometry for diagnosing COPD?
Occasionally 24(29.6) 30(12.5) 54(16.8)
Very frequent 33(40.7) 66(27.5) 99(30.8)
Rarely 6(7.4) 30(12.5) 36(11.2)
Never 18(22.2) 114(47.5) 132(41.1)
4. How frequently do you request for spirometry pre employment test
Very frequent 9(11.1) 24(10.0) 33(10.3)
Occasionally 12(14.8) 30(12.5) 42(13.1)
Rarely 51(63.0) 138(57.5) 189(58.9)
Never/can't recall 9(11.1) 48(20.0) 57(17.8)
5 How confident are you at interpreting spirometry
Not confident 12(14.8) 75(31.3) 87(27.1)
Slightly confident 30(37.0) 138(57.5) 168(52.3)
Very confident 33(40.7) 27(11.3) 60(18.7)
Don't know 6(7.4) 0(0.0) 6(1.9)
P < 0.001 for responses(1-5)BMC Pulmonary Medicine 2009, 9:50 http://www.biomedcentral.com/1471-2466/9/50
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eases. However, only 33.6% appreciated the prognostic
significance of the spirometry test. Furthermore, majority
of the doctors were also aware of its role in the surveil-
lance of occupational lung disease among those at risk of
developing work-related diseases. They also acknowl-
edged its role in pre-operative evaluation of surgical
patients and baseline evaluation of the lung function
among those seeking a life insurance policy. Our data also
revealed that few doctors reported having good knowl-
edge of spirometry and the ability to interpret spirometry
and this result was in agreement with that of the other
studies [10-12]. This finding may be because of lack of
emphasis on spirometry in medical schools and in various
CME programmes organised by the post-graduate colleges
and medical associations. Although the most common
source of knowledge on spirometry was medical schools,
spirometry was poorly taught in most medical schools in
Nigeria as well as in the USA [5]. Further attendance was
poor at conference workshops organised by the National
Respiratory Society. This trend was reflected in the low
attendance figures at CME programmes during the past
five years reported in this study. Factors associated with
poor attendance at spirometry workshops must be
addressed in order to increase the use of spirometry [13].
Table 3: Distribution of doctors' responses to questions on practice of spirometry as related to the type of hospitals
Type of hospital
UTH/FMC DGH/PH
Questions related to practice of spirometry n (%) n (%) Total
1. How frequently do you use spirometry in your practice?*
Very often 78(30.6) 21(31.8) 99(30.8)
Occasionally 123(48.2) 30(45.5) 153(47.7)
Rarely 45(17.7) 9(13.6) 54(16.8)
Never/can't recall 9(3.5) 6(9.1) 15(4.6)
2. How frequently do you request spirometry for monitoring?
for asthma? †
Frequently depending on control 33(12.9) 9(13.6) 42(13.1)
Once a year 12(4.7) 6(9.1) 18(5.6)
Every follow up 72(28.2) 15(22.7) 87(27.1)
Never 138(54.1) 36(54.6) 174(54.2)
3. How frequently do you request spirometry for diagnosing?
COPD? §
Very frequent 87(34.1) 12(18.2) 99(30.8)
Occasionally 39(15.3) 15(22.7) 54(16.8)
Rarely 27(10.6) 9(13.6) 36(11.2)
Never 102(40.0) 30(45.5) 132(41.1)
4. How frequently do you request for spirometry
pre employment test? a
Very frequent 27(10.6) 6(9.1) 33(10.3)
Occasionally 30(11.8) 12(18.2) 42(13.1)
Rarely 150(58.8) 39(59.1) 189(58.9)
Never/can't recall 48(18.8) 9(13.6) 57(17.8)
5. How confident are you at interpreting spirometry? d
Not confident 53(20.8) 24(36.4) 87(27.1)
Slightly confident 129(50.6) 39(59.1) 168(52.3)
Very confident 57(22.4) 3(4.5) 60(18.7)
Don't know 26(10.2) 0(0.0) 6(1.9)
*X 2 = 6.9 df = 3 P =< 0.07, †, X2 = 2.4 df = 3 p = 0.49, § X2 = 9.8 df = 3 p = 0.02, a X2 = 6.5 df = 3
p = 0.09 δ X2 = 121 df = 3 p = 0.02
UTH/FMC = University Teaching Hospital/Federal Medical Centre
DGH/PH = District & General hospital/private Hospital
Table 4: Self -reported barriers to spirometry practice among 
doctor as related to the type of hospital (there may be more 
than one response for the same respondent).
Reasons TH & FMC DGH & PH Total
(n = 260) (n = 71) (n = 331)
Unavailabilty 162(62.3) 45(63.3) 207(62.5)
Unaware of usefulness 39(15.0) 18((25.4) 57(17.2)
Lack of time 28(10.8) 0(0.0) 28(8.5)
Lack of knowledge 15(5.8) 0(0.0) 15(4.5)
No impt to treatment 6(2.3) 3(4.2) 9(2.7)
Patient reluctant 6(2.3) 0(0.0) 6(1.8)
Expensive 3(1.2) 0(0.0) 3(0.9)
Other reasons 1(0.4) 5(7.0) 6(1.8)
X2 = 9.79 df = 7 p = 0.201BMC Pulmonary Medicine 2009, 9:50 http://www.biomedcentral.com/1471-2466/9/50
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Kaminsky and colleagues have reported improvement in
knowledge and use of spirometry through workshops and
seminars [11]. In this study, less than a third (30.8%) of
those surveyed frequently used spirometry in their prac-
tice. The low utilization and poor practice of spirometry
among doctors in this study was similar to reports of other
researchers [11-17]. The low utilization of spirometry in
our study may be due to several factors. The most com-
mon barrier to the practice of spirometry reported by the
doctors was unavailability of spirometers in hospitals
(64.5%). Surprisingly, even among doctors with access to
spirometers, unavailability was reported as the greatest
barrier to the use of spirometry. Other investigators have
reported uncertainty about the impact of a spirometry
test, physician and staff unfamiliarity [11], lack of access
to a well-maintained spirometer and expertise [14], logis-
tical limitations preventing patients from accessing lung
function laboratories [17] and lack of knowledge [18]. We
are not surprised that unavailability was the greatest bar-
rier in this study, as only 25.2% of doctors reported hav-
ing a spirometer in their current hospitals, as opposed to
66.0% in the USA, 64.2% in Australia and 90.9% in Spain
[11,14,15]. Procurement of spirometers is not given top
priority by most health administrators because it does not
generate profits like other routine investigations. It is
ironic that despite the strong epidemiological evidence
demonstrating an association between reduced lung func-
tion and important clinical outcomes as well as the role of
spirometry in early detection of some respiratory diseases
[5,19-21]; it lacks acceptability in clinical practice. The
spirometer is yet to find its rightful place alongside other
routinely used instruments like the glucometer, sphyg-
momanometer and the electrocardiograph (ECG). The
first step towards increasing the acceptance of spirometry
is providing simple portable spirometers to the hospitals.
Secondly, education on spirometry should be enhanced
among doctors as only 18.7% of the surveyed doctors
were very confident at interpreting spirometry tests. Our
findings have a significant implication for management of
respiratory diseases, as mortality from chronic respiratory
disease is projected to rise over the next 10 years in Nigeria
[22].
Strengths and limitations
This is an explorative study in Nigeria and sub-Saharan
Africa that evaluated the knowledge, awareness and prac-
tice of spirometry among doctors. The results of our study
will assist clinicians and hospital administrators in ensur-
ing availability of spirometers in their hospitals and in for-
mulating a policy that will enhance the knowledge and
practice of spirometry. The limitations of this study were
Barriers to spirometry practice among doctor Figure 1
Barriers to spirometry practice among doctor.BMC Pulmonary Medicine 2009, 9:50 http://www.biomedcentral.com/1471-2466/9/50
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difficulties in obtaining current addresses and employ-
ment details of registered practitioners in Nigeria.
Conclusion
Most Nigerian doctors are aware of the role of spirometry,
but they lack adequate knowledge to practice it and inter-
pret the test results in their hospital. Unavailability was
the greatest barrier to the use of spirometry. There is a
need to make spirometer widely available in hospitals in
order to encourage the practice of spirometry among doc-
tors. We also need to address the other barriers obstruct-
ing the practice of spirometry and improve the knowledge
of spirometry among doctors. These measures will eventu-
ally translate into improvements in the quality of respira-
tory care.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
OOD conceived and designed the study, conducted data
collection and analysis and wrote the first draft of the
manuscript. OB coordinated and contributed to final draft
of the manuscript. CCO contributed to data collection
technical and editorial review. FKS assisted in data collec-
tion and final drafting. OAB contributed to data collec-
tion, or analysis and interpretation of data. KCN
contributed to data collection and regional coordination
of the study. AKS contributed to editorial review and final
draft of the manuscript. All authors read and approved the
final manuscript.
Appendix 1
List of selected hospital in nigeria that participated in the 
study
Enugu State University Teaching Hospital Park lane
Enugu
University of Nigeria Teaching Hospital Enugu, Nigeria
Federal Medical Centre Abakaliki, Ebonyi State
Mile 4 Missionary Hospital Abakaliki, Ebonyi State
Federal Medical Centre Yola, Adamawa State
Adamawa State Specialist Hospital, Adamawa State
Galbose Hospital Yola, Adamawa State
University of Ilorin Teaching Hospital, Ilorin
Sobi Specialist Hospital, Sobi, Ilorin
Olanrewaju Hospital, Ilorin
Federal Medical Centre Ido-Ekiti, Nigeria
University Teaching Hospital, Ado-Ekiti, Nigeria
Adeniyi hospital Ado-Ekiti, Nigeria
Federal Medical Centre Birnin Kebbi, Nigeria
Sir Yahaya Memorial Specialist Hospital, Birnin-kebbi
Sokoto Clinic, Sokoto 
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